These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36342287)

  • 1. Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak.
    Cameron DR; Pitton M; Oberhaensli S; Schlegel K; Prod'hom G; Blanc DS; Jakob SM; Que YA
    Microbiol Spectr; 2022 Dec; 10(6):e0274322. PubMed ID: 36342287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
    Diorio-Toth L; Irum S; Potter RF; Wallace MA; Arslan M; Munir T; Andleeb S; Burnham CD; Dantas G
    Microbiol Spectr; 2022 Jun; 10(3):e0076622. PubMed ID: 35638817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.
    Atrissi J; Milan A; Bressan R; Lucafò M; Petix V; Busetti M; Dolzani L; Lagatolla C
    Microbiol Spectr; 2021 Oct; 9(2):e0118621. PubMed ID: 34585948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis.
    Sherrard LJ; Wee BA; Duplancic C; Ramsay KA; Dave KA; Ballard E; Wainwright CE; Grimwood K; Sidjabat HE; Whiley DM; Beatson SA; Kidd TJ; Bell SC
    J Cyst Fibros; 2022 Jan; 21(1):e35-e43. PubMed ID: 33775602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer Program for Detection and Analyzing the Porin-Mediated Antibiotic Resistance of Bacteria.
    Savinova TA; Samchenko AA; Bocharova YA; Mayansky NA; Chebotar IV
    Sovrem Tekhnologii Med; 2021; 13(6):15-22. PubMed ID: 35265355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.
    Richardot C; Plésiat P; Fournier D; Monlezun L; Broutin I; Llanes C
    Int J Antimicrob Agents; 2015 May; 45(5):529-32. PubMed ID: 25735764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
    Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
    Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.
    Hirabayashi A; Kato D; Tomita Y; Iguchi M; Yamada K; Kouyama Y; Morioka H; Tetsuka N; Yagi T
    J Med Microbiol; 2017 Nov; 66(11):1562-1572. PubMed ID: 28984565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
    Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
    Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
    J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
    Quale J; Bratu S; Gupta J; Landman D
    Antimicrob Agents Chemother; 2006 May; 50(5):1633-41. PubMed ID: 16641429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil.
    Campana EH; Xavier DE; Petrolini FV; Cordeiro-Moura JR; Araujo MR; Gales AC
    Braz J Infect Dis; 2017; 21(1):57-62. PubMed ID: 27916604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran.
    Mirsalehian A; Kalantar-Neyestanaki D; Taherikalani M; Jabalameli F; Emaneini M
    J Epidemiol Glob Health; 2017 Sep; 7(3):155-159. PubMed ID: 28756823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.